Company intelligence / Profile preview

Pathomics

Toronto, Ontario, Canadapathomicshealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Pathomics develops advanced computational tools to analyze multiplexed biomedical images—enabling researchers and pathologists to extract quantitative insights from complex spatial biology datasets. Their solutions streamline workflows in translational research by integrating multi-modal data and providing explainable AI-driven results. The company is recognized as an innovator in open-source digital pathology platforms.

Therapeutic areas: Oncology
Modalities: Computational analysis for spatial biology and digital pathology images
Industry: Pathology

Drug pipeline

2 assets

EarlyCDT-Lung

Commercial

Indications: Lung cancer detection

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Pathomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathomics.

Explore the full profile